What CRO Laboratories Inc does

CRO Laboratories Inc is a privately held Contract Research Organization (CRO) headquartered in Dallas, Texas, that operates two integrated lines of business. The first is contract research services spanning medicinal chemistry (custom library design, lead generation and optimization, synthesis of organic scaffolds, pro-drugs, and new chemical entities), process development (synthetic route design and optimization), scale-up (gram to kilogram, non-GMP and GMP), cGMP manufacturing delivered through a partner network for intermediates, APIs, and drug substances, and analytical services (HPLC method development, GC and LC-MS analysis, chiral separation, purity determinations). The second is a catalog manufacturing and supply business offering over 4,000 in-stock products including deuterium-labeled compounds, 13C-labeled compounds, stable isotope-labeled drug substances, analytical reference standards, pharmaceutical standards, drug impurities, metabolites, active pharmaceutical ingredients, screening libraries, and specialty research chemicals, with flexible production from milligram to kilogram scale.

The company's underlying technology is rooted in synthetic and medicinal chemistry rather than software or AI platforms, with a stated differentiator being specialization in deuterium and 13C labeling chemistry — a niche area serving pharmaceutical R&D, bioequivalence studies, and regulatory filings. Production assets are concentrated at the Dallas headquarters, with GMP manufacturing executed via partner facilities rather than fully owned plants. Customer-facing channels are primarily direct: a company website that supports request-quote, quick-order, and customer-service workflows, supplemented by dedicated email addresses (info@, order@, [email protected]), phone (214-366-2238), and fax lines.

CRO Laboratories serves four customer segments — pharmaceutical companies, biotechnology firms, academic institutions, and government organizations — on a global basis. Revenue is generated through two mechanics: catalog unit sales of in-stock compounds at price points ranging from approximately $15 to $2,550 depending on compound and quantity, and quote-based custom synthesis plus contract research projects sized individually by scope. The go-to-market motion is sales-led with no identified digital marketing, channel partner, or distribution intermediary, and there is no disclosed revenue, headcount, funding, or ownership structure in the available data.

Name

CRO Laboratories Inc

Legal name

CRO Laboratories Inc.

Website

https://crolaboratories.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

CRO Laboratories Inc is a Dallas-based contract research organization providing synthetic and medicinal chemistry services and a catalog of over 4,000 pharmaceutical research compounds to pharmaceutical, biotechnology, academic, and government clients worldwide.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Chemicals

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Chemical Manufacturing (325)

SIC

Wholesale-Chemicals & Allied Products (5160), Chemicals & Allied Products (2800)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Custom synthesis services
• Deuterium-labeled compounds
• Analytical reference standards
• Contract research organization
• Pharmaceutical impurity standards

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Chemical Product Sales: Sale of in-stock catalog products including deuterated compounds, stable isotopes, analytical reference standards, pharmaceutical standards, drug impurities, metabolites, APIs, and specialty research chemicals. Over 4,000 in-stock catalog products available in sizes from mg-scale to gram-scale catalog items to semi-bulk and bulk production quantities.
2. Contract Research Services: Medicinal chemistry services including design/synthesis of custom libraries, lead generation and optimization, synthesis of organic scaffolds, synthesis of pro-drugs and new chemical entities; process development, custom synthesis, scale-up, and GMP manufacturing services
3. Custom Synthesis: Synthesis of intermediates, synthetic route development, metabolites synthesis/characterization, impurities isolation, synthesis and characterization for pharmaceutical and biotech clients

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CRO Laboratories Inc. manufactures and supplies over 4,000 in-stock chemical products including deuterium-labeled and 13C-labeled compounds, stable isotope-labeled drug substances, analytical reference standards, pharmaceutical standards, drug impurities, metabolites, and APIs at scales from milligram to kilogram. It also delivers contract chemistry services covering medicinal chemistry, custom synthesis, process development, scale-up, GMP manufacturing, and analytical services for pharmaceutical, biotechnology, academic, and government organizations worldwide.

Product overview

CRO Laboratories Inc is a Contract Research Organization (CRO) providing end-to-end chemistry services and a comprehensive portfolio of pharmaceutical research products. The company operates two integrated divisions: (1) Contract Research Services encompassing medicinal chemistry, process development, custom synthesis, scale-up, GMP manufacturing, and analytical services supporting drug discovery through commercialization; and (2) a Manufacturing and Catalog division offering over 4,000 in-stock products including deuterium-labeled compounds, 13C-labeled compounds, stable isotope-labeled drug substances, analytical reference standards, pharmaceutical standards, drug impurities, metabolites, APIs, and specialty research chemicals. The product portfolio spans from milligram-scale catalog items to multi-kilogram production quantities, enabling pharmaceutical, biotechnology, academic, and government clients to advance research programs from early discovery through regulatory filings and commercial success.

Differentiator

Problem solved

Functional benefit

Products and services

• Deuterium-Labeled Compounds Deuterium-labeled chemical compounds used in drug discovery, pharmaceutical research, and analytical applications as internal standards for mass spectrometry and to support metabolic studies. Targeted at pharmaceutical and biotech R&D teams.
• 13C-Labeled Compounds Carbon-13 labeled compounds used as stable isotope tracers in pharmaceutical research, metabolomics, and analytical methodology development. Targeted at pharmaceutical, biotech, and academic researchers.
• Analytical Reference Standards High-purity reference standards used in pharmaceutical quality control, analytical method validation, and regulatory compliance testing. Targeted at pharmaceutical quality control and analytical labs.
• Drug Impurities Impurity standards including degradation products, synthesis by-products, and regulatory-required impurity reference materials for pharmaceutical analysis. Targeted at pharmaceutical development and quality control teams.
• Active Pharmaceutical Ingredients (APIs) Bulk active pharmaceutical ingredients and drug substances available from milligram to kilogram scale for pharmaceutical development and commercial manufacturing. Targeted at pharmaceutical companies and CDMOs.
• Screening Libraries Curated collections of compounds for high-throughput screening in drug discovery and hit identification programs. Targeted at biotech and pharmaceutical discovery groups.
• Medicinal Chemistry Services Custom library design and synthesis, lead generation and optimization, organic scaffold synthesis, and synthesis of pro-drugs and new chemical entities for drug discovery programs. Targeted at pharmaceutical and biotech discovery teams.
• Custom Synthesis Services Custom synthesis of intermediates, synthetic route development, metabolite synthesis and characterization, and impurity isolation and characterization. Targeted at pharmaceutical and biotechnology companies requiring bespoke chemistry.
• Process Development and Scale-Up Services Synthetic route design and optimization, process scale-up from laboratory to multi-kilogram scale, and pharmaceutical raw material production. Targeted at pharmaceutical companies advancing candidates from lab to commercial scale.
• GMP Manufacturing Services cGMP manufacturing services for pharmaceutical intermediates, active pharmaceutical ingredients, new chemical entities, and drug substances delivered through partner facilities. Targeted at pharmaceutical companies requiring GMP-grade material for clinical and commercial use.
• Analytical Services Analytical and preparatory HPLC method development, GC and LC-MS analysis, optical rotations and chiral separation, and purity determinations. Targeted at pharmaceutical and biotech R&D and quality control teams.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cayman Chemical: Cayman manufactures biochemicals, reference standards, impurities, metabolites, and research reagents for pharma, academic, and government researchers. Its catalog and customer base closely mirror CRO Labs' research chemicals and standards business.
• Clearsynth: Clearsynth specializes in stable isotope-labeled compounds, reference standards, and impurity standards for pharma and biotech. It overlaps directly with CRO Labs' deuterated compounds and analytical reference standards catalog.
• Cerilliant (Sigma-Aldrich/Merck): Cerilliant, now part of MilliporeSigma, is a leading supplier of certified reference standards and stable isotope-labeled compounds for clinical and forensic testing. It is a direct competitor in the analytical reference standards and stable isotope segments.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies, biochemicals, research reagents, and specialty chemicals to academic and pharma researchers. It overlaps with CRO Labs in the broader specialty research chemicals and drug discovery reagents catalog.
• Curia (formerly AMRI): Curia provides contract research, development, and manufacturing services including custom synthesis, medicinal chemistry, process development, and API manufacturing. It is a direct competitor in the chemistry CRO services category that CRO Labs also serves.
• Cambridge Isotope Laboratories (CIL): CIL is the leading global manufacturer of stable isotope-labeled compounds (deuterium, 13C, 15N, 18O) used as reference standards and research tools. It is the most direct competitor to CRO Labs' deuterium and 13C-labeled product line, serving the same pharma, biotech, and academic customers.
• Toronto Research Chemicals (TRC): TRC manufactures organic chemicals, deuterated compounds, reference standards, impurities, and metabolites for pharmaceutical R&D. It competes head-to-head with CRO Labs across the analytical reference standards and drug-impurity catalog business.
• Syncom: Syncom is a custom synthesis and contract chemistry CRO specializing in process development, scale-up, and GMP manufacturing of APIs and intermediates in Europe. It is comparable to CRO Labs' process development and scale-up services.
• Asymchem: Asymchem is a contract development and manufacturing organization (CDMO) offering custom synthesis, process development, scale-up, and GMP manufacturing for intermediates and APIs. It competes with CRO Labs in the chemistry CRO/CDMO services space.

Broad incumbents

• MilliporeSigma (Sigma-Aldrich): MilliporeSigma, the life science arm of Merck KGaA, is the broadest incumbent supplier of stable isotopes, deuterated solvents, reference standards, APIs, and research chemicals. It is a much larger competitor that overlaps with CRO Labs' catalog across nearly every product category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cro-laboratories

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRO Laboratories Inc